peptideInjectable
ACE-031
Also known as: Ramatercept
Half-life
48 h
Typical timing
any
Food rule
either
Default unit
mg
Studied for
Overview
ACE-031, also known as Ramatercept, is a synthetic peptide that has been investigated for its potential role in increasing muscle mass. It is not currently approved for medical use in humans. The compound functions by acting as a decoy receptor for myostatin, a protein that naturally limits muscle growth. By binding to myostatin, ACE-031 aims to reduce myostatin's ability to signal and thus promote increased muscle development. Research into ACE-031 has largely focused on conditions characterized by muscle wasting or weakness, such as Duchenne muscular dystrophy (DMD). Early clinical development was discontinued for reasons that have not been fully disclosed, though challenges in pharmacokinetics and potential side effects were mentioned in some reports (DrugBank). It is considered an investigational compound and its long-term effects and safety profile in humans are not fully established.
Deep dive
Tap a section to expand.
Known interactions
- Category rule: peptide × hormoneNote
Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.
Track bloodwork with a provider; don't assume combinations are neutral.
Sources referenced
- DrugBank
- MedlinePlus
- PubMed
- ClinicalTrials.gov (for phase 2 trial information)
- Company statements (for discontinuation information)
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the peptide category or studied for the same goals.
Related benefits
Other compounds studied for the same benefits as ACE-031.
Continue exploring
See every compound Stackwise catalogues for these goals.
Track ACE-031 in Stackwise
Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.
Sign up free →